TokenPost·
Axsome Therapeutics Reports Q3 Revenue Up 51.9% to $259.7 Million
Its GAAP loss was 25 cents per share, 38 cents better than estimates. Shares gained 2.5% in premarket trading.
More news
- The DefiantJito Names First Outside BAM Node Operators
- TokenPostHKMA Expands EnsembleTX for 24/7 Settlement of Tokenized Deposits
- TokenPostSuper League Adds Eight Bitcoin as Metaplanet Deal Awaits Closing
- Crypto BriefingTether burns 2 billion USDT from its Treasury address
- TokenPostTom Lee Expects Markets to Stay Strong Through Year-End
- crypto.newsBlackRock’s Ethereum fund sheds 580K ETH as monthly exits mount